Cocrystal Pharma (COCP) Inventory Average (2011 - 2013)
Cocrystal Pharma (COCP) posted Inventory Average of $1.6 million for Q2 2013, down 3.79% sequentially from $1.7 million in Q1 2013, and down 22.12% YoY from $2.1 million in Q2 2012.
Cocrystal Pharma (COCP) Inventory Average (2011 - 2013) Analysis & Trends
Cocrystal Pharma has reported Inventory Average for 3 years, with the latest figure at $1.6 million in Q2 2013.
- Quarterly Inventory Average fell 22.12% year-over-year to $1.6 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was $1.6 million (down 22.12% YoY) and the FY2012 annual result came in at $1.7 million, down 19.67% from the prior year.
- Inventory Average retreated to $1.6 million in Q2 2013 per COCP's latest filing, from $1.7 million in the prior quarter.
- Over five years, Inventory Average peaked at $3.1 million in Q3 2011 and troughed at $1.6 million in Q2 2013.
- A 3-year average of $2.1 million and a median of $2.0 million in 2012 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2012 and 2013: Inventory Average dropped 27.35% in 2012, then fell 6.52% in 2013.
- Over 3 years, Inventory Average stood at $2.6 million in 2011, then retreated by 26.97% to $1.9 million in 2012, then decreased by 15.77% to $1.6 million in 2013.
- According to Business Quant data, Inventory Average over the past three periods registered $1.6 million, $1.7 million, and $1.9 million for Q2 2013, Q1 2013, and Q4 2012 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Cocrystal Pharma | 15.86 Mn | 13.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 1.60 Mn |
| Mar 31, 2013 | 1.66 Mn |
| Dec 31, 2012 | 1.90 Mn |
| Sep 30, 2012 | 2.26 Mn |
| Jun 30, 2012 | 2.06 Mn |
| Mar 31, 2012 | 1.78 Mn |
| Dec 31, 2011 | 2.60 Mn |
| Sep 30, 2011 | 3.11 Mn |